Stocksigma LogoStocksigma Logo

Nath Bio-Genes (India) Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

■ Revenue: 4,074 (-7.1% YoY | -87.6% QoQ) ■ EBITDA: 464 (-24.1% YoY | -86.8% QoQ) ■ EBITDA Margin (%): 11.4 (-254 bps YoY | +67 bps QoQ) ■ PAT: 41.9

Nath Bio-Genes (India) Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

Nath Bio-Genes (India) Ltd · Financial Result · 14 Nov 2026, 10:43 pm

Nath Bio-Genes (India) Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 4,074 (-7.1% YoY | -87.6% QoQ) ■ EBITDA: 464 (-24.1% YoY | -86.8% QoQ) ■ EBITDA Margin (%): 11.4 (-254 bps YoY | +67 bps QoQ) ■ PAT: 41.9 (-84.8% YoY | -98.7% QoQ) ■ EPS (INR): 0.22 (-84.8% YoY | -98.7% QoQ)

Original exchange filing (PDF)

More announcements from Nath Bio-Genes (India) Ltd

All Nath Bio-Genes (India) Ltd announcements